InfiMed debuts cardiac software

Article

InfiMed debuts cardiac softwareMedical image processing firm InfiMed has introduced Cardiac View CV 1000, a cardiac cath lab imaging software package. The CV 1000 is a diagnostic-quality imaging tool designed for viewing cardiac cath lab patient

InfiMed debuts cardiac software

Medical image processing firm InfiMed has introduced Cardiac View CV 1000, a cardiac cath lab imaging software package. The CV 1000 is a diagnostic-quality imaging tool designed for viewing cardiac cath lab patient studies, according to the Liverpool, NY-based company. Workstation features include real-time review and edge enhancement, 1000-line display resolution, zoom, and image export to a hospital’s intranet or the Web. InfiMed claims that the performance parameters of the DICOM-based CV 1000 were previously available only on hardware-based image workstations at 10 to 20 times the cost. InfiMed will also make CV 1000 available over the Internet. The company is offering free 14-day trials of the software via a downloadable Internet file or as a compact disk. As part of its future plans, the firm will also introduce a family of related products for cardiovascular applications.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.